3d Printed Drugs Market Size And Share

  • Report Code : TIPRE00010199
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

3D Printed Drugs Market Share, Size, and Trends by 2031

Buy Now

3D Printed Drugs Market Report 3D Printed Drugs Market Scope and Analysis 3D Printed Drugs Market Size and Share

3D Printed Drugs Market: Strategic Insights

3D Printed Drugs Market

  • CAGR (2023 - 2031)
    9.6%
  • Market Size 2023
    US$ 33.58 Million
  • Market Size 2031
    US$ 83.08 Million

Market Dynamics

GROWTH DRIVERS
  • Increasing Adoption of Personalised Drugs
FUTURE TRENDS
  • Increasing Prevalence of Dysphagia is expected to drive the market
OPPORTUNITIES
  • Adoption of Novel Technologies in 3D Drugs Printing to Streamline Procedural Outcomes

Key Players

  • APRECIA PHARMACEUTICALS LLC
  • FabRx LTD
  • Cycle Pharmaceuticals
  • GLAXOSMITHKLINE PLC
  • ASTRAZENECA
  • Tvasta
  • Merck KGGA

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Dosage Forms
  • Tablets
  • Capsules
  • Multi Drug Implant
  • Nanoparticles
  • Solutions
Technology
  • Inkjet Printing
  • Direct Write
  • Zip Dose
  • Thermal Inkjet Printing
  • Fused Deposition Modeling
  • Powder Bed Printing
  • Stereolithography
  • Semi Solid Extrusion